Sugi Predict

Sugi Predict / Compounds / SCHEMBL3600700

SCHEMBL3600700

SCHEMBL3600700

Nc1ccc(Sc2c(O)c3c(=O)n(-c4ccccc4)c4ccccc4c3oc2=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.52
▸ ALDH1A1 P00352 4/20 0.52
▸ MEN1 O00255 4/20 0.52
▸ POLB P06746 4/20 0.52
▸ TSHR P16473 1/20 0.52
▸ BRCA1 P38398 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ KDM4E B2RXH2 4/20 0.40
▸ RXFP1 Q9HBX9 2/20 0.40
▸ CYP1A2 P05177 4/20 0.38
▸ CYP3A4 P08684 4/20 0.38
▸ CYP2C19 P33261 4/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ PRNP P04156 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KDM1A O60341 1/20 0.36
▸ RECQL P46063 2/20 0.36
▸ CYP2D6 P10635 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13440539 0.92 ALDH1A1 (0.57) KMT2AALDH1A1MEN1POLBTSHR
SCHEMBL3606590 0.92 ALDH1A1 (0.54) KMT2AALDH1A1MEN1POLBTSHR
SCHEMBL13440579 0.90 ALDH1A1 (0.55) KMT2AALDH1A1MEN1POLBTSHR
SCHEMBL13441119 0.90 ALDH1A1 (0.52) KMT2AALDH1A1MEN1POLBTSHR
SCHEMBL13440773 0.90 ALDH1A1 (0.52) KMT2AALDH1A1MEN1POLBTSHR
SCHEMBL3600696 0.89 ALDH1A1 (0.49) KMT2AALDH1A1MEN1POLBTSHR
SCHEMBL4597039 0.88 ALDH1A1 (0.52) KMT2AALDH1A1MEN1POLBTSHR
SCHEMBL13441023 0.87 KMT2A (0.49) KMT2AALDH1A1MEN1POLBTSHR
SCHEMBL13440778 0.87 ALDH1A1 (0.49) KMT2AALDH1A1MEN1POLBTSHR
SCHEMBL13440780 0.87 KMT2A (0.56) KMT2AALDH1A1MEN1POLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. 2010-03-18 — — US disclosed
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. 2010-03-18 — — US disclosed
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. 2010-03-18 — — US disclosed
WO-2008127274-A2 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. (US) 2008-10-23 — — WO disclosed
WO-2008127274-A2 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. (US) 2008-10-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF NSUN3, TARBP1, TRMT1 KMT2A 2284/4885ALDH1A1 3494/4885MEN1 4179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.